Organic Chemistry Methods TRIZ Cases
- Indolocarbazole OLED Compounds for Balanced Charge Transport
Carbazole-substituted indolocarbazole compounds balance OLED charge transport, improving efficiency, voltage, and device lifespan.
- Aryl-Heterocyclic OLED Compounds for Long-Life, Low-Voltage Devices
This case uses aryl and heterocyclic groups to improve carrier transport, recombination efficiency, and OLED lifetime at lower voltage.
- ALP001E Crystalline and Salt Forms for Stability and Solubility
Specific solvents and controlled temperatures produce ALP001E crystal forms that address hydrolysis, stability, solubility, and release.
- Organometallic Compound Composition for Blue Phosphorescence and Low RC Delay
This case uses Formula 1 organometallic compounds to emit blue phosphorescence while reducing capacitance, charge, and RC delay.
- Amine Hole Transport Compounds for Efficient, Long-Life OLEDs
A substituted dibenzofuran or dibenzothiophene amine lowers driving voltage and extends light-emitting element lifespan.
- Organic Compounds for OLED Hole Transport and Electron Blocking
This OLED case uses Chemical Formula A compounds in transport layers to block electrons, lower voltage, and improve efficiency and lifetime.
- Zn-based organic coordination nanoparticle and preparation method therefor, photoresist composition containing same, and use thereof
A 1–4 nm Zn-based nanoparticle uses ligand coordination and photoacid response to improve EUV resolution and line roughness.
- Pyrrolotriazine Salt Crystal Forms for Selective MNK1/2 Inhibition
Pyrrolotriazine salt crystal forms combine selective MNK1/2 inhibition, stability, and reduced impact on normal cells.
- Crystalline (17-β)-3-Oxoandrost-4-en Dodecanoate for Bioavailability
This case uses a defined crystalline dodecanoate form to balance physical stability, dissolution, and sustained testosterone release.
- AMG 176 Crystalline Salt and Solvate Forms for Solubility and Stability
Compare crystalline AMG 176 salts and solvates that improve solubility and stability for pharmaceutical formulation development.
- Compound I′ Crystalline Form for Stable NEP Inhibitor Manufacturing
Defined PXRD patterns and thermal profiles yield a non-hygroscopic crystal form for stable NEP inhibitor processing.
- Continuous Apremilast Synthesis with Direct Crystallization
A DMSO-based continuous process combines apremilast reaction and direct crystallization to simplify isolation and support scale-up.
- Crystalline Psilocin–Psilocybin Forms for Stability and Absorption
XRPD-characterized crystalline forms combine psilocin absorption with psilocybin stability in a defined pharmaceutical composition.
- One-Pot Oxidative Lactone Synthesis for Lower-Cost Enantio-Enriched Products
Hydroxyalkenes undergo epoxidation, rearrangement, oxidation, and ring closure in one vessel for high-yield, enantio-enriched lactones.
- Crystalline Anhydrous Succinate Salt for SHP2 Inhibitor Solubility
This case uses a crystalline anhydrous succinate salt to balance SHP2 inhibitor purity, stability, and solubility.
- Circularly polarized light-emitting material and use, light-emitting display device, and display apparatus
A helical-chiral tetradentate ligand improves chemical and thermal stability while enabling efficient circularly polarized OLED emission.
- Palbociclib Synthesis: Segmented Addition for Impurity Control
Portioned compound II addition and sub-40°C coupling limit impurities while enabling over 99% purity and crystalline Form G isolation.
- Deuterated Arylamine Compounds for Low-Voltage, Durable OLEDs
A phenyl-naphthyl linker and carbazole amine improve hole transport, heat resistance, efficiency, and OLED lifespan.
- Ruxolitinib Phosphate Process for Chiral Purity and Impurity Control
An anhydrous, parameter-controlled process forms crystalline (R)-ruxolitinib phosphate with high chiral purity and fewer impurities.